1. 2358Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM. (28th August 2018) Authors: Mohan, M; Al-Talabany, S; McKinnie, A; Mordi, I; Singh, J S S; Gandy, S; Khan, F; Choy, A M; Houston, J G; George, J; Struthers, A D; Lang, C C Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 42 Is Mitochondrial Function Measured by 31P Magnetic Resonance Spectroscopy Associated with Physical Performance in Older People with Functional Impairment?. (16th March 2021) Authors: Chungath, R R; Witham, M D; Clarke, C L; Hutcheon, A; Gandy, S; Gingles, C; Priba, L; Nicholas, S; Cavin, I; Sumukadas, D; Struthers, A D; George, J Journal: Age and ageing Issue: Volume 50(2021)Supplement 1 Page Start: i12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dapagliflozin improves left ventricular myocardial longitudinal function in people with type 2 diabetes. (25th November 2020) Authors: Brown, A.J.M; Gandy, S; McCrimmon, R; Struthers, A; Lang, C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P2860MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients. (28th August 2018) Authors: Al-Talabany, S; Weir Mccall, J; Mohan, M; Singh, J; Mordi, I; Gandy, S; Khan, F; Choy, A; Houston, G; Ewan, P; George, J; Struthers, A; Lang, C Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗